GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuantaMatrix Inc (XKRX:317690) » Definitions » Research & Development

QuantaMatrix (XKRX:317690) Research & Development : ₩4,770 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is QuantaMatrix Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. QuantaMatrix's Research & Development for the three months ended in Mar. 2025 was ₩1,181 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ₩4,770 Mil.

QuantaMatrix Research & Development Historical Data

The historical data trend for QuantaMatrix's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuantaMatrix Research & Development Chart

QuantaMatrix Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 4,776.26 5,121.81 5,492.24 5,777.75 4,789.75

QuantaMatrix Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,200.22 1,210.49 1,107.55 1,271.49 1,180.75

QuantaMatrix Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩4,770 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QuantaMatrix  (XKRX:317690) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

QuantaMatrix Research & Development Related Terms

Thank you for viewing the detailed overview of QuantaMatrix's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

QuantaMatrix Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuantaMatrix Inc (XKRX:317690) » Definitions » Research & Development
Comparable Companies
XKRX:043100 XKRX:246960 XKRX:263690 XKRX:460470 XKRX:304840 XKRX:149980 XKRX:462510 XKRX:104540 XKRX:058110 XKRX:238120 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
N/A
Address
131, Gasan digital 1-ro, Geumcheon-gu, 16th floor, Bidong (Gasan-dong, BYC High City), Seoul, KOR, 08506
Website
https://www.quantamatrix.com
QuantaMatrix Inc is engaged in research and development, production, and sales of in vitro diagnostic (IVD) medical devices that utilize substances collected from the human body, such as blood, feces, body fluids, and saliva, for the purpose of disease prevention and diagnosis, prognosis prediction, and assessment of health status and treatment effectiveness, targeting domestic and foreign general hospitals and testing contract institutions.

QuantaMatrix Headlines

No Headlines